Repro Med Systems, Inc. (KRMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
KRMD POWR Grades
- KRMD scores best on the Value dimension, with a Value rank ahead of 49.59% of US stocks.
- The strongest trend for KRMD is in Momentum, which has been heading down over the past 31 weeks.
- KRMD's current lowest rank is in the Momentum metric (where it is better than 16.13% of US stocks).
KRMD Stock Summary
- For KRMD, its debt to operating expenses ratio is greater than that reported by only 5.4% of US equities we're observing.
- With a year-over-year growth in debt of -88.98%, Repro Med Systems Inc's debt growth rate surpasses just 2.22% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Repro Med Systems Inc is reporting a growth rate of -386.98%; that's higher than just 5.14% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Repro Med Systems Inc are IVAC, ICAD, SOI, METC, and CTSO.
- Visit KRMD's SEC page to see the company's official filings. To visit the company's web site, go to www.korumedical.com.
KRMD Price Target
For more insight on analysts targets of KRMD, see our KRMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $7.88 | Average Broker Recommendation | 1.83 (Hold) |
KRMD Stock Price Chart Interactive Chart >
KRMD Price/Volume Stats
| Current price | $4.18 | 52-week high | $10.96 |
| Prev. close | $4.31 | 52-week low | $2.70 |
| Day low | $4.12 | Volume | 236,500 |
| Day high | $4.35 | Avg. volume | 390,103 |
| 50-day MA | $3.91 | Dividend yield | N/A |
| 200-day MA | $4.92 | Market Cap | 185.97M |
Repro Med Systems, Inc. (KRMD) Company Bio
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
Latest KRMD News From Around the Web
Below are the latest news stories about Repro Med Systems Inc that investors may wish to consider to help them evaluate KRMD as an investment opportunity.
KRMD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 25, 2021 in the Class Action Filed on Behalf of Repro Med Systems, Inc. Limited ShareholdersNew York, New York--(Newsfile Corp. - May 25, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Repro Med Systems, Inc. (NASDAQ: KRMD) alleging that the Company violated federal securities laws.Class Period: August 4, 2020 and January 25, 2021Lead Plaintiff Deadline: May 25, 2021Learn more about your recoverable losses in KRMD:http://www.kleinstocklaw.com/pslra-1/repro-med-systems-inc-loss-submission-form?id=16166&from=5The filed complaint alleges that Repro Med Systems, Inc. made materially false and/or ... |
FINAL DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses to Contact the FirmLOS ANGELES, CA / ACCESSWIRE / May 25, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Repro Med Systems, Inc. d/b/a KORU Medical Systems ("KURO" or "the Company") (NASDAQ:KRMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U. |
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Repro Med Systems, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 25, 2021 - KRMDNew York, New York--(Newsfile Corp. - May 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Repro Med Systems, Inc. ("Repro Med Systems") (NASDAQ: KRMD) between August 4, 2020 and January 25, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New ... |
Last Chance to Actively Participate Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLCNEW YORK, NY / ACCESSWIRE / May 25, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) ("KORU" or "the Company") (NASDAQ:KRMD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired KORU securities between August 4, 2020 and January 25, 2021, both dates inclusive (the "Class Period"). |
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmLos Angeles, California--(Newsfile Corp. - May 25, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Repro Med Systems, Inc. d/b/a KORU Medical Systems ("KURO" or "the Company") (NASDAQ: KRMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 4, ... |
KRMD Price Returns
| 1-mo | -3.02% |
| 3-mo | 7.18% |
| 6-mo | -33.86% |
| 1-year | -54.81% |
| 3-year | 257.23% |
| 5-year | 1,206.25% |
| YTD | -30.56% |
| 2020 | -7.81% |
| 2019 | 295.76% |
| 2018 | 32.00% |
| 2017 | 150.00% |
| 2016 | -9.09% |
Loading social stream, please wait...